ArticleHealth research policy and systems2018
Impact assessment of Iran's health technology assessment programme.
Article in Health research policy and systems, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Systematic review and policy dialogue to determine challenges in evidence-informed health policy-making: findings of the SASHA study.Health research policy and systems · 2021Pooled it
- Strategic health policy priorities for health technology assessment development in Iran.Journal of preventive medicine and hygiene · 2026Article
- Level of health technology assessment process-related skills among doctors in Croatia: a cross-sectional survey study.International journal of technology assessment in health care · 2026Article
- Impact upfront: novel format for Novo Nordisk Foundation funding.Health research policy and systems · 2025Review
- Unleashing the potential: the imperative of political support for health technology assessment in Iran.Health economics review · 2024Article
- Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.Health research policy and systems · 2024Review
- Research gaps identified in Iran's health technology assessment reports.Health research policy and systems · 2023Review
- Healthcare priority-setting criteria and social values in Iran: an investigation of local evidence.International journal of technology assessment in health care · 2023Review
- The role of Iran's context for the development of health technology assessment: challenges and solutions.Health economics review · 2023Article
- How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review.Pathogens and global health · 2023Article
- Article
- The challenges facing programs for the prevention and control of non-communicable diseases in Iran: a qualitative study of senior managers' viewpoints.BMC health services research · 2022Article
- Correction to: Impact assessment of Iran's health technology assessment programme.Health research policy and systems · 2018Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundFollowing approximately 10 years from the beginning of Iran's national Health Technology Assessment (HTA) programme, the present study aims to evaluate its success by examining the impact of HTA and identifying the determinant factors leading to the implementation of HTA report results.
methodsThe triangulation method was employed herein. HTA reports were initially identified and their impact and determinant factors were then examined from the perspectives of both researchers (by preparing a questionnaire according to the Payback model and sending it to HTA principle investigators) and stakeholders (semi-structured interviews held with each HTA stakeholder). Simultaneously, the quality of the HTA reports was examined with relevant critical appraisal checklists.
resultsThe impact of 19 equipment technologies and four pharmaceutical technologies were assessed in this study. Twenty researchers replied (response rate, 86.96%) to the questionnaire on the impact of HTA reports from the researcher's perspective. To assess the impact of HTA reports from the stakeholder's perspective, seven policy-makers were chosen and interviewed as the main target audience. The most common step taken to disseminate the results of the HTA projects was publication. Conducting the HTA had taught researchers and their colleagues' new skills and had facilitated the securing of research grants from other organisations. Most reports had used the systematic review method but the relevant details had been scarcely presented regarding outcomes, costs and analysis. The greatest impact of HTA reports on decision-making had been on policy-makers providing and allocating finances. Barriers in stewardship, identification and prioritisation of topics, performance and dissemination of HTA results were the main barriers of implementing HTAs.
conclusionsIn most aspects, the status of HTA impact reports need improvement. Thus far, the barriers and facilitators of the HTA programme in Iran have been investigated in other studies. These findings should be pooled to reach a solution that can be actively applied to the health system to improve the status quo of HTA in Iran.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.